{"id":"experimental-for-steroids-and-antifungals","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"The drug is designed to address conditions requiring both immunosuppressive/anti-inflammatory effects (via steroid mechanism) and antifungal activity. This dual mechanism may be particularly useful in treating fungal infections in immunocompromised patients or conditions where both steroid and antifungal effects are therapeutically beneficial.","oneSentence":"This experimental agent combines steroid and antifungal properties to modulate immune response while providing antifungal activity.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:12:06.631Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Fungal infections in immunocompromised patients (investigational)"}]},"trialDetails":[{"nctId":"NCT04680884","phase":"PHASE3","title":"Empirical Steroids and/or Antifungals in Immunocompromised Patients With Acute Respiratory Failure From Undetermined Etiology: a Multicenter Double-blind Randomized Controlled Trial","status":"UNKNOWN","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2020-12-21","conditions":"Acute Respiratory Failure, Immunocompromised Patients","enrollment":420}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Experimental for steroids and antifungals","genericName":"Experimental for steroids and antifungals","companyName":"Assistance Publique - Hôpitaux de Paris","companyId":"assistance-publique-h-pitaux-de-paris","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This experimental agent combines steroid and antifungal properties to modulate immune response while providing antifungal activity. Used for Fungal infections in immunocompromised patients (investigational).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}